A detailed history of Orion Investment CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Orion Investment CO holds 794,700 shares of IOVA stock, worth $8.77 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares
794,700
Holding current value
$8.77 Million
% of portfolio
2.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.78 - $14.19 $6.18 Million - $11.3 Million
794,700 New
794,700 $6.37 Billion

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Orion Investment CO Portfolio

Follow Orion Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Orion Investment CO with notifications on news.